Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2011-08-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Impact of Corneal Width on Surgically Induced Astigmatism (SIA) and Functional Results After Bimanual 1.4 mm Microincision Cataract Surgery (B-MICS), Coaxial 1.8 mm MICS (C-MICS) and 2.4 mm Small Incision Cataract Surgery (C-SICS).
NCT05510869
Comparison of Toric IOL Implantation and Opposite Clear Corneal Incision During Cataract Surgery to Correct Corneal Astigmatism
NCT01763151
Blue-Blocking IOLs in Combined Surgery
NCT00537992
A Single Centre Study to Analyze Cataract Surgery Following Femtosecond Laser-Assisted and Manual Cataract Surgery
NCT01769313
Intraocular Lens Power Calculation for Combined Phaco-vitrectomy Procedures
NCT03856346
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To compare refractive outcomes after combined cataract and vitreoretinal surgery.
Methods:
Patients with a diagnosis of vitreoretinal disorder and a coexisting significant cataract were randomly assigned to be treated with a microincision cataract surgery and a 23-gauge vitrectomy (treatment group 1) or with a smallincision cataract surgery and a 23-gauge vitrectomy (treatment group 2).
Main outcome measures:
Refractive outcomes, stability of the intraocular lens (IOL), intraocular pressure (IOP) and functional outcomes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Micro
Microincision cataract surgery
Combined Micro- Surgery
Microincision Cataract Surgery combined with 23-gauge/25-gauge/27 gauge Vitrectomy
Small
Smallincision cataract surgery
Combined Small-Surgery
Smallincision cataract surgery combined with 23 gauge vitrectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Combined Micro- Surgery
Microincision Cataract Surgery combined with 23-gauge/25-gauge/27 gauge Vitrectomy
Combined Small-Surgery
Smallincision cataract surgery combined with 23 gauge vitrectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* combined surgery
* age over 60 years
* IOL master for preoperative intraocularlens (IOL) calculation
Exclusion Criteria
* macular edema, proliferative diabetic retinopathy
* myopia or hyperopia more than 5 diopters, astigmatism more than 2 diopters
* previous refractive surgery, retinal detachment surgery, glaucoma surgery and vitrectomy
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Christiane I. Falkner-Radler
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susanne Binder, Univ.Prof.Dr.
Role: PRINCIPAL_INVESTIGATOR
Ludwig Boltzmann Institute of Retinology and biomicroscopic Lasersurgery
Christiane I Falkner-Radler, M.D.
Role: STUDY_CHAIR
Ludwig Boltzmann Institut of Retinology and biomicroscopic Lasersurgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rudolf Foundation Clinic
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Katharina Krepler, Priv.Doz.Dr.
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FR-6-CI-2010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.